Physician profile
Timothy E Bass
NPI 1205353844
$1,706.16
in general payments reported to CMS, 2019-2025
10 companies · $429 in 2025
The $429 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.89 · 2020: $256 · 2021: $36.66 · 2022: $227 · 2023: $408 · 2024: $255 · 2025: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,093.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,092.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $503.86 | 2019-2025 | Total30, Clareon, Hydrus Microstent |
| Bausch & Lomb Americas INC. | $346.98 | 2022-2025 | Infuse, Infuse Multifocal |
| Sun Pharmaceutical Industries INC. | $262.31 | 2020-2025 | Cequa |
| Coopervision INC. | $256.32 | 2022-2025 | Myday Contact Lens, Clariti Contact Lens |
| Allergan, INC. | $86.00 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $80.37 | 2020-2021 | |
| Optos, INC. | $64.77 | 2019 | |
| Novartis Pharmaceuticals Corporation | $48.75 | 2022 | |
| Oyster Point Pharma, INC. | $34.70 | 2023 | Tyrvaya |
| Johnson & Johnson Vision Care, INC. | $22.10 | 2023 | Acuvue |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Bass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.